Entrada Therapeutics, Inc.
US ˙ NasdaqGM ˙ US29384C1080

SecurityTRDA / Entrada Therapeutics, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership67,147 shares
Latest Disclosed Value $ 690,272
Barclays Plc reports 10.75% increase in ownership of TRDA / Entrada Therapeutics, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 67,147 shares of Entrada Therapeutics, Inc. (US:TRDA) valued at $690,271 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 60,630 shares of Entrada Therapeutics, Inc.. This represents a change in shares of 10.75% during the quarter. The current value of the position is $470,029 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F ENTRADA THERAPEUTICS COM 29384C108 67,147 6,517 10.75 690 96.58 0.0002
2026-03-31 2025-09-30 13F/A-3 ENTRADA THERAPEUTICS COM 29384C108 60,630 2,548 4.39 352 -10.00 0.0001
2026-03-19 2025-09-30 13F/A-2 ENTRADA THERAPEUTICS COM 29384C108 45,110 -12,972 721 0.0002
2025-11-12 2025-09-30 13F ENTRADA THERAPEUTICS COM 29384C108 60,630 2,548 352 0.0001
2026-02-27 2025-06-30 13F/A-2 ENTRADA THERAPEUTICS COM 29384C108 58,082 18,431 46.48 390 8.94 0.0001
2025-08-14 2025-06-30 13F/A-1 ENTRADA THERAPEUTICS COM 29384C108 58,082 18,431 0 0.0001
2025-08-13 2025-06-30 13F ENTRADA THERAPEUTICS COM 29384C108 58,082 18,431 0 0.0000
2026-03-17 2025-03-31 13F/A-1 ENTRADA THERAPEUTICS COM 29384C108 39,651 -11,714 -22.81 358 -59.68 0.0001
2025-05-15 2025-03-31 13F ENTRADA THERAPEUTICS COM 29384C108 39,651 -11,714 0 0.0001
2026-03-19 2024-12-31 13F/A-1 ENTRADA THERAPEUTICS COM 29384C108 51,365 6,255 13.87 888 23.33 0.0002
2025-02-13 2024-12-31 13F ENTRADA THERAPEUTICS COM 29384C108 51,365 6,255 1 0.0002
2026-03-31 2024-09-30 13F/A-2 ENTRADA THERAPEUTICS COM 29384C108 45,110 30,585 210.57 721 249.51 0.0002
2024-11-19 2024-09-30 13F/A-1 ENTRADA THERAPEUTICS COM 29384C108 45,110 30,585 1 0.0002
2024-11-15 2024-09-30 13F ENTRADA THERAPEUTICS COM 29384C108 45,110 30,585 1 0.0001
2026-03-23 2024-06-30 13F/A-1 ENTRADA THERAPEUTICS COM 29384C108 14,525 -7,992 -35.49 207 -35.42 0.0001
2024-08-14 2024-06-30 13F ENTRADA THERAPEUTICS COM 29384C108 14,525 -7,992 0 0.0001
2026-03-24 2024-03-31 13F/A-1 ENTRADA THERAPEUTICS COM 29384C108 22,517 -9,213 -29.04 319 -33.26 0.0001
2024-05-15 2024-03-31 13F ENTRADA THERAPEUTICS COM 29384C108 22,517 -9,213 0 0.0001
2026-03-25 2023-12-31 13F/A-1 ENTRADA THERAPEUTICS COM 29384C108 31,730 25,798 434.90 479 413.98 0.0002
2024-02-15 2023-12-31 13F ENTRADA THERAPEUTICS COM 29384C108 31,730 25,798 0 0.0002
2026-03-26 2023-09-30 13F/A-1 ENTRADA THERAPEUTICS COM 29384C108 5,932 -508 -7.89 94 -4.12 0.0001
2023-11-07 2023-09-30 13F ENTRADA THERAPEUTICS COM 29384C108 5,932 -508 0 0.0001
2026-03-30 2023-06-30 13F/A-2 ENTRADA THERAPEUTICS COM 29384C108 6,440 -3,788 -37.04 98 -34.46 0.0001
2023-09-20 2023-06-30 13F/A-1 ENTRADA THERAPEUTICS COM 29384C108 6,440 -3,788 0 0.0001
2023-08-03 2023-06-30 13F ENTRADA THERAPEUTICS COM 29384C108 6,440 -3,788 0 0.0001
2026-03-30 2023-03-31 13F/A-1 ENTRADA THERAPEUTICS COM 29384C108 10,228 -544 -5.05 148 2.07 0.0001
2023-05-04 2023-03-31 13F ENTRADA THERAPEUTICS COM 29384C108 10,228 -544 0 0.0001
2026-03-30 2022-12-31 13F/A-1 ENTRADA THERAPEUTICS COM 29384C108 10,772 9,557 786.58 146 663.16 0.0001
2023-02-13 2022-12-31 13F ENTRADA THERAPEUTICS COM 29384C108 10,772 9,557 0 0.0001
2022-11-03 2022-09-30 13F ENTRADA THERAPEUTICS COM 29384C108 1,215 1,179 3,275.00 19 0.0000
2022-08-12 2022-06-30 13F ENTRADA THERAPEUTICS COM 29384C108 36 -1,673 -97.89 0 -100.00
2022-05-16 2022-03-31 13F ENTRADA THERAPEUTICS COM 29384C108 1,709 1,709 16 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.